Dr. Madelyn Burkart
Principal Investigator
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
ALL Research
Biography
Dr. Madelyn Burkart is a faculty member at Wake Forest School of Medicine specializing in pediatric acute lymphoblastic leukemia (ALL) research and treatment. Her work focuses on developing novel therapeutic approaches for pediatric ALL patients, with an emphasis on improving outcomes and reducing treatment-related toxicity.
Dr. Burkart's research contributes to advancing treatment options for children with ALL, exploring new therapeutic strategies and combinations that can improve survival rates while minimizing long-term side effects.
Official Profile
Learn more about Dr. Madelyn Burkart's clinical practice and research at Wake Forest School of Medicine:
View official profile at Wake Forest School of MedicineResearch Contributions
Explore Additional Research
Find additional publications and research by Dr. Madelyn Burkart:
Search PubMed for publications by Dr. Madelyn BurkartCurrent Research Projects
ALL Active
Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia.
Principal Investigator: Dr. Madelyn Burkart
Institution: Lurie Children's Hospital
Location
Chicago, Illinois
Timeline
Start: January 2023
Completion: December 2026